Skip to main content
Erschienen in: Skeletal Radiology 2/2013

01.02.2013 | Scientific Article

Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher's disease type I and III

verfasst von: Ahmed Abdel Khalek Abdel Razek, Ahmed Abdalla, Abeer Fathy, Ahmed Megahed

Erschienen in: Skeletal Radiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess apparent diffusion coefficient (ADC) as a quantitative parameter for detection of vertebral bone marrow infiltration in children with Gaucher’s disease type I and III.

Material and methods

Prospective study was conducted on 20 infants and children (14 M, 6 F; aged 31–61 months; mean age 46 months) with Gaucher’s disease type I (n = 13) and III (n = 7), and 20 age and sex matched controls. They underwent routine and diffusion-weighted MR imaging of the lumbar spine using echo planar imaging with b value of 0, 500 and 1000 sec/mm2. The ADC value of the lumbar vertebral bone marrow was compared in different phenotypes and genotypes; and correlated with bone marrow burden score (BMB), chitotriosidase level, hemoglobin and platelet count.

Results

The mean ADC value of marrow infiltration in patients with Gaucher’s disease (0.39 ± 0.06 × 10−3 mm2/s) was significantly lower (P = 0.001) than that of vertebral bone marrow in controls (0.54 ± 0.05 × 10−3 mm2/s). The cut-off ADC value used to differentiate patients with Gaucher’s disease from controls was (0.47 × 10−3 mm2/s); with sensitivity of 95 %; specificity of 95 % and area under the curve of 0.986. The L444P/L444P mutation had significantly lower ADC value compared to other mutations (P = 0.001). The mean ADC value of the bone marrow negatively correlated with BMB (r = −0.831; P = 0.001), and biomarkers of disease activity including chitotriosidase (r = −0.542; P = 0.014), hemoglobin (r = −0.727; P = 0.001) and platelets (r = −0.698; P = 0.001).

Conclusion

We concluded that there is significant difference in the ADC value of vertebral bone marrow between children with Gaucher’s disease and controls, and the ADC value correlated well with genotyping and some biomarkers of disease activity.
Literatur
1.
Zurück zum Zitat Vom Dahl S, Poll L, Di Rocco M, et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin. 2006;22:1045–64.PubMedCrossRef Vom Dahl S, Poll L, Di Rocco M, et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin. 2006;22:1045–64.PubMedCrossRef
2.
Zurück zum Zitat Grabowski G. Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet. 2008;372:1263–71.PubMedCrossRef Grabowski G. Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet. 2008;372:1263–71.PubMedCrossRef
3.
Zurück zum Zitat Maas M, Hangartner T, Mariani G, et al. Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease. Skeletal Radiol. 2008;37:185–8.PubMedCrossRef Maas M, Hangartner T, Mariani G, et al. Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease. Skeletal Radiol. 2008;37:185–8.PubMedCrossRef
4.
Zurück zum Zitat Maas M, Kuijper M, Akkerman E. From Gaucher's Disease to Metabolic Radiology: Translational Radiological Research and Clinical Practice. Semin Musculoskelet Radiol. 2011;15:301–6.PubMedCrossRef Maas M, Kuijper M, Akkerman E. From Gaucher's Disease to Metabolic Radiology: Translational Radiological Research and Clinical Practice. Semin Musculoskelet Radiol. 2011;15:301–6.PubMedCrossRef
5.
Zurück zum Zitat Alfonso Palacín P, Pocoví M. Genetics of Gaucher's disease. Genotype-phenotype correlation. Med Clin. 2011;137 Suppl 1:17–22.CrossRef Alfonso Palacín P, Pocoví M. Genetics of Gaucher's disease. Genotype-phenotype correlation. Med Clin. 2011;137 Suppl 1:17–22.CrossRef
6.
Zurück zum Zitat Wei R, Hughes H, Boucher S, et al. X-ray and biochemical analysis of N370S mutant human acid β-glucosidase. J Biol Chem. 2011;286:299–308.PubMedCrossRef Wei R, Hughes H, Boucher S, et al. X-ray and biochemical analysis of N370S mutant human acid β-glucosidase. J Biol Chem. 2011;286:299–308.PubMedCrossRef
7.
Zurück zum Zitat Koprivica V, Stone D, Park J, et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet. 2000;66:1777–86.PubMedCrossRef Koprivica V, Stone D, Park J, et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet. 2000;66:1777–86.PubMedCrossRef
8.
Zurück zum Zitat Aerts J, Kallemeijn W, Wegdam W, et al. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. J Inherit Metab Dis. 2011;34:605–19.PubMedCrossRef Aerts J, Kallemeijn W, Wegdam W, et al. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. J Inherit Metab Dis. 2011;34:605–19.PubMedCrossRef
9.
Zurück zum Zitat Aerts J, van Breemen M, Bussink A, et al. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease. Acta Paediatr Suppl. 2008;97:7–14.PubMedCrossRef Aerts J, van Breemen M, Bussink A, et al. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease. Acta Paediatr Suppl. 2008;97:7–14.PubMedCrossRef
10.
Zurück zum Zitat Barone R, Sotgiu S, Musumeci S. Plasma chitotriosidase in health and pathology. Clin Lab. 2007;53:321–33.PubMed Barone R, Sotgiu S, Musumeci S. Plasma chitotriosidase in health and pathology. Clin Lab. 2007;53:321–33.PubMed
11.
Zurück zum Zitat Schoonhoven A, Rudensky B, Elstein D, et al. Monitoring of Gaucher patients with a novel chitotriosidase assay. Clin Chim Acta. 2007;381:136–9.PubMedCrossRef Schoonhoven A, Rudensky B, Elstein D, et al. Monitoring of Gaucher patients with a novel chitotriosidase assay. Clin Chim Acta. 2007;381:136–9.PubMedCrossRef
12.
Zurück zum Zitat Giraldo P, Cenarro A, Alfonso P, et al. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers). Haematologica. 2001;86:977–84.PubMed Giraldo P, Cenarro A, Alfonso P, et al. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers). Haematologica. 2001;86:977–84.PubMed
13.
Zurück zum Zitat RoccoM D, Giona F, Carubbi F, et al. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Hematol. 2008;98:1211–8. RoccoM D, Giona F, Carubbi F, et al. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Hematol. 2008;98:1211–8.
14.
Zurück zum Zitat Zimran A, Altarescu G, Rudensky B, et al. Survey of hematological aspects of Gaucher disease. Hematol. 2005;10:151–6.CrossRef Zimran A, Altarescu G, Rudensky B, et al. Survey of hematological aspects of Gaucher disease. Hematol. 2005;10:151–6.CrossRef
15.
Zurück zum Zitat Spectre G, Roth B, Ronen G, et al. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding. Br J Haematol. 2011;153:372–8.PubMedCrossRef Spectre G, Roth B, Ronen G, et al. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding. Br J Haematol. 2011;153:372–8.PubMedCrossRef
16.
Zurück zum Zitat Katz R, Booth T, Hargunani R, et al. Radiological aspects of Gaucher disease. Skeletal Radiol. 2011;40:1505–13.PubMedCrossRef Katz R, Booth T, Hargunani R, et al. Radiological aspects of Gaucher disease. Skeletal Radiol. 2011;40:1505–13.PubMedCrossRef
17.
Zurück zum Zitat Maas M, Poll L, Terk M. Imaging and quantifying skeletal involvement in Gaucher disease. Br J Radiol. 2002;75(S1):A13–24.PubMed Maas M, Poll L, Terk M. Imaging and quantifying skeletal involvement in Gaucher disease. Br J Radiol. 2002;75(S1):A13–24.PubMed
18.
Zurück zum Zitat Roca M, Mota J, Alfonso P, et al. S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease. Eur J Radiol. 2007;62:132–7.PubMedCrossRef Roca M, Mota J, Alfonso P, et al. S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease. Eur J Radiol. 2007;62:132–7.PubMedCrossRef
19.
Zurück zum Zitat Terk M, Esplin J, Lee K, et al. MR imaging of patients with type 1 Gaucher’s disease: relationship between bone and visceral changes. AJR Am J Roentgenol. 1995;165:599–604.PubMed Terk M, Esplin J, Lee K, et al. MR imaging of patients with type 1 Gaucher’s disease: relationship between bone and visceral changes. AJR Am J Roentgenol. 1995;165:599–604.PubMed
20.
Zurück zum Zitat Vlieger E, Maas M, Akkerman E, et al. Vertebra Disc Ratio as a Parameter for Bone Marrow Involvement and Its Application in Gaucher Disease. J Comput Assist Tomogr. 2002;26:843–8.PubMedCrossRef Vlieger E, Maas M, Akkerman E, et al. Vertebra Disc Ratio as a Parameter for Bone Marrow Involvement and Its Application in Gaucher Disease. J Comput Assist Tomogr. 2002;26:843–8.PubMedCrossRef
21.
Zurück zum Zitat DeMayo R, Haims A, McRae M, et al. Correlation of MRI-Based Bone Marrow Burden Score with Genotype and Spleen Status in Gaucher’s Disease. AJR Am J Roentgenol. 2008;191:115–23.PubMedCrossRef DeMayo R, Haims A, McRae M, et al. Correlation of MRI-Based Bone Marrow Burden Score with Genotype and Spleen Status in Gaucher’s Disease. AJR Am J Roentgenol. 2008;191:115–23.PubMedCrossRef
22.
Zurück zum Zitat Maas M, Hollak C, Akkerman E, et al. Quantification of Skeletal Involvement in Adults with Type 1 Gaucher’s Disease: Fat Fraction Measured by Dixon Quantitative Chemical Shift Imaging as a Valid Parameter. AJR Am J Roentgenol. 2002;179:961–5.PubMed Maas M, Hollak C, Akkerman E, et al. Quantification of Skeletal Involvement in Adults with Type 1 Gaucher’s Disease: Fat Fraction Measured by Dixon Quantitative Chemical Shift Imaging as a Valid Parameter. AJR Am J Roentgenol. 2002;179:961–5.PubMed
23.
Zurück zum Zitat Bley T, Wieben O, Uhl M. Diffusion-Weighted MR Imaging in Musculoskeletal Radiology: Applications in Trauma, Tumors, and Inflammation. Magn Reson Imaging Clin North Am. 2009;17:263–75.CrossRef Bley T, Wieben O, Uhl M. Diffusion-Weighted MR Imaging in Musculoskeletal Radiology: Applications in Trauma, Tumors, and Inflammation. Magn Reson Imaging Clin North Am. 2009;17:263–75.CrossRef
24.
Zurück zum Zitat Raya J, Dietrich O, Reiser M, et al. Methods and Applications of Diffusion Imaging of Vertebral Bone Marrow. J Magnet Resonance Imaging. 2006;24:1207–20.CrossRef Raya J, Dietrich O, Reiser M, et al. Methods and Applications of Diffusion Imaging of Vertebral Bone Marrow. J Magnet Resonance Imaging. 2006;24:1207–20.CrossRef
25.
Zurück zum Zitat Nonomura Y, Yasumoto M, Yoshimura R, et al. Relationship between bone marrow cellularity and apparent diffusion coefficient. J Mag Reson Imaging. 2001;13:757–60.CrossRef Nonomura Y, Yasumoto M, Yoshimura R, et al. Relationship between bone marrow cellularity and apparent diffusion coefficient. J Mag Reson Imaging. 2001;13:757–60.CrossRef
26.
Zurück zum Zitat MacKenzie J, Gonzalez L, Hernandez A, et al. Diffusion-weighted and diffusion tensor imaging for pediatric musculoskeletal disorders. Pediatr Radiol. 2007;37:781–8.PubMedCrossRef MacKenzie J, Gonzalez L, Hernandez A, et al. Diffusion-weighted and diffusion tensor imaging for pediatric musculoskeletal disorders. Pediatr Radiol. 2007;37:781–8.PubMedCrossRef
27.
Zurück zum Zitat Davies E, Seunarine K, Banks T, et al. Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging. J Inherit Metab Dis. 2011;34:549–53.PubMedCrossRef Davies E, Seunarine K, Banks T, et al. Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging. J Inherit Metab Dis. 2011;34:549–53.PubMedCrossRef
28.
Zurück zum Zitat Abdel Razek AA, Abd El Gaber N, Abdalla A, et al. Apparent diffusion coefficient value of the brain in patients with Gaucher’s disease type II and type III. Neuroradiol. 2009;51:773–9.CrossRef Abdel Razek AA, Abd El Gaber N, Abdalla A, et al. Apparent diffusion coefficient value of the brain in patients with Gaucher’s disease type II and type III. Neuroradiol. 2009;51:773–9.CrossRef
29.
Zurück zum Zitat Maas M, van Kuijk C, Stoker J, et al. (2003) Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging—initial experience. radiol. 2003;229:554–61.CrossRef Maas M, van Kuijk C, Stoker J, et al. (2003) Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging—initial experience. radiol. 2003;229:554–61.CrossRef
30.
Zurück zum Zitat Deghady A, Marzouk I, El-Shayeb A, et al. Coagulation abnormalities in type 1 Gaucher disease in children. Pediatr Hematol Oncol. 2006;23:411–7.PubMedCrossRef Deghady A, Marzouk I, El-Shayeb A, et al. Coagulation abnormalities in type 1 Gaucher disease in children. Pediatr Hematol Oncol. 2006;23:411–7.PubMedCrossRef
Metadaten
Titel
Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher's disease type I and III
verfasst von
Ahmed Abdel Khalek Abdel Razek
Ahmed Abdalla
Abeer Fathy
Ahmed Megahed
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Skeletal Radiology / Ausgabe 2/2013
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-012-1464-8

Weitere Artikel der Ausgabe 2/2013

Skeletal Radiology 2/2013 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.